355 related articles for article (PubMed ID: 19877044)
1. Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis.
Appel H; Ruiz-Heiland G; Listing J; Zwerina J; Herrmann M; Mueller R; Haibel H; Baraliakos X; Hempfing A; Rudwaleit M; Sieper J; Schett G
Arthritis Rheum; 2009 Nov; 60(11):3257-62. PubMed ID: 19877044
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of periostin and factors associated with new bone formation in ankylosing spondylitis: Periostin may be associated with the Wnt pathway.
Solmaz D; Uslu S; Kozacı D; Karaca N; Bulbul H; Tarhan EF; Ozmen M; Can G; Akar S
Int J Rheum Dis; 2018 Feb; 21(2):502-509. PubMed ID: 28941122
[TBL] [Abstract][Full Text] [Related]
3. Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation.
Poole KE; van Bezooijen RL; Loveridge N; Hamersma H; Papapoulos SE; Löwik CW; Reeve J
FASEB J; 2005 Nov; 19(13):1842-4. PubMed ID: 16123173
[TBL] [Abstract][Full Text] [Related]
4. Relationship of bone morphogenetic proteins to disease activity and radiographic damage in patients with ankylosing spondylitis.
Park MC; Park YB; Lee SK
Scand J Rheumatol; 2008; 37(3):200-4. PubMed ID: 18465455
[TBL] [Abstract][Full Text] [Related]
5. Sclerostin expression and functions beyond the osteocyte.
Weivoda MM; Youssef SJ; Oursler MJ
Bone; 2017 Mar; 96():45-50. PubMed ID: 27888056
[TBL] [Abstract][Full Text] [Related]
6. Negative Association Between Sclerostin and INSL3 in Isolated Human Osteocytes and in Klinefelter Syndrome: New Hints for Testis-Bone Crosstalk.
Di Nisio A; De Toni L; Rocca MS; Ghezzi M; Selice R; Taglialavoro G; Ferlin A; Foresta C
J Clin Endocrinol Metab; 2018 May; 103(5):2033-2041. PubMed ID: 29452406
[TBL] [Abstract][Full Text] [Related]
7. Circulating periostin levels in patients with AS: association with clinical and radiographic variables, inflammatory markers and molecules involved in bone formation.
Sakellariou GT; Anastasilakis AD; Bisbinas I; Oikonomou D; Gerou S; Polyzos SA; Sayegh FE
Rheumatology (Oxford); 2015 May; 54(5):908-14. PubMed ID: 25349442
[TBL] [Abstract][Full Text] [Related]
8. Serum Sclerostin Level Among Egyptian Rheumatoid Arthritis Patients: Relation to Disease Activity, Bone Mineral Density and Radiological Grading.
Mehaney DA; Eissa M; Anwar S; Fakhr El-Din S
Acta Reumatol Port; 2015; 40(3):268-74. PubMed ID: 26535777
[TBL] [Abstract][Full Text] [Related]
9. Osteocyte deficiency in hip fractures.
Delgado-Calle J; Arozamena J; García-Renedo R; García-Ibarbia C; Pascual-Carra MA; González-Macías J; Riancho JA
Calcif Tissue Int; 2011 Oct; 89(4):327-34. PubMed ID: 21874545
[TBL] [Abstract][Full Text] [Related]
10. Sclerostin rather than Dickkopf-1 is associated with mSASSS but not with disease activity score in patients with ankylosing spondylitis.
Sun W; Tian L; Jiang L; Zhang S; Zhou M; Zhu J; Xue J
Clin Rheumatol; 2019 Apr; 38(4):989-995. PubMed ID: 30443790
[TBL] [Abstract][Full Text] [Related]
11. Sclerostin regulates release of bone mineral by osteocytes by induction of carbonic anhydrase 2.
Kogawa M; Wijenayaka AR; Ormsby RT; Thomas GP; Anderson PH; Bonewald LF; Findlay DM; Atkins GJ
J Bone Miner Res; 2013 Dec; 28(12):2436-48. PubMed ID: 23737439
[TBL] [Abstract][Full Text] [Related]
12. Serum Sclerostin as a Possible Biomarker in Ankylosing Spondylitis: A Case-Control Study.
Perrotta FM; Ceccarelli F; Barbati C; Colasanti T; De Socio A; Scriffignano S; Alessandri C; Lubrano E
J Immunol Res; 2018; 2018():9101964. PubMed ID: 29854850
[TBL] [Abstract][Full Text] [Related]
13. Comparison of tissue transglutaminase 2 and bone biological markers osteocalcin, osteopontin and sclerostin expression in human osteoporosis and osteoarthritis.
Tarquini C; Mattera R; Mastrangeli F; Agostinelli S; Ferlosio A; Bei R; Orlandi A; Tarantino U
Amino Acids; 2017 Mar; 49(3):683-693. PubMed ID: 27357308
[TBL] [Abstract][Full Text] [Related]
14. Fetuin-A is related to syndesmophytes in patients with ankylosing spondylitis: a case control study.
Tuylu T; Sari I; Solmaz D; Kozaci DL; Akar S; Gunay N; Onen F; Akkoc N
Clinics (Sao Paulo); 2014 Dec; 69(10):688-93. PubMed ID: 25518021
[TBL] [Abstract][Full Text] [Related]
15. Sclerostin and the regulation of bone formation: Effects in hip osteoarthritis and femoral neck fracture.
Power J; Poole KE; van Bezooijen R; Doube M; Caballero-Alías AM; Lowik C; Papapoulos S; Reeve J; Loveridge N
J Bone Miner Res; 2010 Aug; 25(8):1867-76. PubMed ID: 20200987
[TBL] [Abstract][Full Text] [Related]
16. Pigment epithelium-derived factor (PEDF) reduced expression and synthesis of SOST/sclerostin in bone explant cultures: implication of PEDF-osteocyte gene regulation in vivo.
Li F; Cain JD; Tombran-Tink J; Niyibizi C
J Bone Miner Metab; 2019 Sep; 37(5):773-779. PubMed ID: 30607618
[TBL] [Abstract][Full Text] [Related]
17. Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes.
Kim JY; Lee SK; Jo KJ; Song DY; Lim DM; Park KY; Bonewald LF; Kim BJ
Life Sci; 2013 Mar; 92(10):533-40. PubMed ID: 23357248
[TBL] [Abstract][Full Text] [Related]
18. Osteocyte recruitment declines as the osteon fills in: interacting effects of osteocytic sclerostin and previous hip fracture on the size of cortical canals in the femoral neck.
Power J; Doube M; van Bezooijen RL; Loveridge N; Reeve J
Bone; 2012 May; 50(5):1107-14. PubMed ID: 22353552
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers of bone metabolism in ankylosing spondylitis in relation to osteoproliferation and osteoporosis.
Klingberg E; Nurkkala M; Carlsten H; Forsblad-d'Elia H
J Rheumatol; 2014 Jul; 41(7):1349-56. PubMed ID: 24931960
[TBL] [Abstract][Full Text] [Related]
20. Treatment of a mouse model of ankylosing spondylitis with exogenous sclerostin has no effect on disease progression.
Haynes KR; Tseng HW; Kneissel M; Glant TT; Brown MA; Thomas GP
BMC Musculoskelet Disord; 2015 Nov; 16():368. PubMed ID: 26612313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
